329 - Treatments Targeting Neurotransmission in Alzheimer's Disease: January 2023

AMiNDR: A Month in Neurodegenerative Disease Research

This episode covers some papers from January 2023 on treatments focused on repairing the neurotransmitter imbalance in Alzheimer's disease. We hope you enjoy listening as Christy summarizes this exciting research—from the discovery of new therapeutics to the synthesis of drugs.

Sections in this episode:

Drug Screening (3:37)

New Drugs (7:00)

Synthesized Drugs (13:35)

--------------------------------------------------------------

To find the numbered bibliography with all the papers covered in this episode, click here, or use the link below:

https://drive.google.com/file/d/1BkF6ofShRYL_ggRRFKvNsHvBz4PrLfXr/view?usp=share_link

To access the folder with ALL our bibliographies, follow this link (it will be updated as we publish episodes and process bibliographies), or use the link below:

https://drive.google.com/drive/folders/1bzSzkY9ZHzzY8Xhzt0HZfZhRG1Gq_Si-?usp=sharing

You can also find all of our bibliographies on our website: amindr.com.

--------------------------------------------------------------

We at AMiNDR are eager to hear from you! We opened up a survey available until the end of April for you to tell us what we are doing well, and where we can improve. Access the survey at tinyurl.com/amindrsurvey. All survey responses will be anonymous. By doing the survey, you can choose to enter a draw for a $15USD gift card for any location you choose!

--------------------------------------------------------------

Follow-up on social media for more updates!

Twitter: @AMiNDR_podcast

Instagram: @AMiNDR.podcast

Facebook: AMiNDR

Youtube: AMiNDR Podcast

LinkedIn: AMiNDR Podcast

Email: [e-mail]

--------------------------------------------------------------

Please help us spread the word about AMiNDR to your friends, colleagues, and networks! And if you could leave us a rating and/or review on your streaming app of choice (Apple Podcasts, Spotify, or wherever you listen to the podcast), that would be greatly appreciated! It helps us a lot and we thank you in advance for leaving a review! Don’t forget to subscribe to hear about new episodes as they come out too.

Thank you to our sponsor, the Canadian Consortium of Neurodegeneration in Aging, or CCNA, for their financial support of this podcast. This helps us to stay on the air and bring you high quality episodes. You can find out more about the CCNA on their website: https://ccna-ccnv.ca/.

Our team of volunteers works tirelessly each month to bring you every episode of AMiNDR. This episode was scripted and hosted by Ellen Koch, edited by Michelle Grover, and reviewed by Christy Yu and Anusha Kamesh. The bibliography and wordcloud were created by Lara Onbasi (www.wordart.com).

Big thanks to the sorting team for taking on the enormous task of sorting all of the Alzheimer’s Disease papers into episodes each month. For January 2023, the sorters were Elyn Rowe, Christy Yu, Eden Dubchak, Ben Cornish, Kevin Nishimura, Anelya Gandy, Salodin Al-Achkar, and Rob Cloke. Also, props to our management team, which includes Sarah Louadi, Ellen Koch, Naila Kuhlmann, Elyn Rowe, Anusha Kamesh, Lara Onbasi, Joseph Liang, and Judy Cheng, for keeping everything running smoothly.

Our music is from "Journey of a Neurotransmitter" by musician and fellow neuroscientist Anusha Kamesh; you can find the original piece and her other music on soundcloud under Anusha Kamesh or on her YouTube channel, AKMusic.

https://www.youtube.com/channel/UCMH7chrAdtCUZuGia16FR4w

--------------------------------------------------------------

If you are interested in joining the team, send us your CV by email. We are specifically looking for help with sorting abstracts by topic, abstract summaries and hosting, audio editing, creating bibliographies, and outreach/marketing. However, if you are interested in helping in other ways, don't hesitate to apply anyways.

--------------------------------------------------------------

*About AMiNDR: *

Learn more about this project and the team behind it by listening to our first episode: "Welcome to AMiNDR!"